Motor Intervention Whit the Intorus Tool on Children With Down Syndrome

NCT ID: NCT05740046

Last Updated: 2023-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-01

Study Completion Date

2023-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to test in people with down syndrome how does the INTORUS tool influence their psychomotor development. The main question it aims to answer is:

\- Does the INTORUS tool improve psychomotor development in people with Down Syndrome? The intervention program will be carried out during the Functional Habilitation sessions and will be carried out by the center's professionals. These sessions must be carried out in a quiet environment, without distractions so that the user can concentrate on carrying out the activities. It is important that the user attends the sessions in comfortable, sleeveless clothing, to allow the tool to slide smoothly through their upper limbs.

Each session will consist of several exercises with their corresponding rest breaks described in the Intervention Protocol. Each session attendance will be recorded following an attendance record model created for the occasion.

Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the psychomotor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the psychomotor level with the INTORUS device.

Randomization will be carried out using the Oxford Minimization and Randomization software.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

POPULATION The population of interest are users of the Functional Habilitation Service of the Centers of the Down Syndrome Association of Cáceres and Plasencia

INCLUSION CRITERIA

* Users with Down Syndrome
* Ages between 4 and 18 years.
* Informed consent signed by parents/guardians.

EXCLUSION CRITERIA

* Users without Down Syndrome.
* Under 4 years and over 18 years.

A total of approximately 100 users will participate in the study. Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the psychomotor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the psychomotor level with the INTORUS device.

Randomization will be carried out using the OxMaR (Oxford Minimization and Randomization) software.

PROJECT REGISTRATION The project has been approved by the Bioethics and Biosafety Commission of the University of Extremadura as of 12/19/2022.

INTERVENTION PROGRAM

The intervention program will be carried out during the Functional Habilitation sessions and will be carried out by the center's professionals. These sessions must be carried out in a quiet environment, without distractions so that the user can concentrate on carrying out the activities. It is important that the user attends the sessions in comfortable, sleeveless clothing, to allow the tool to slide smoothly through their upper limbs.

Each session will consist of several exercises with their corresponding rest breaks described in the Intervention Protocol. Each session attendance will be recorded following an attendance record model created for the occasion.

INTERVENTION PROTOCOL

To carry out the intervention sessions, all participants will follow the same protocol for the use of INTORUS. It is a protocol created for the study of increasing difficulty in which the participants advance to a higher level once they have passed the lower level.

EVALUATION

The evaluations will be carried out prior to the start of treatment, at 20 weeks of treatment and at 40 weeks of treatment once the intervention program has concluded.

The tools used to carry out the evaluation will be:

* Questionnaire of participating sociodemographic variables
* Pediatric Balanced Scale (PBS)
* Berg Balance Scale
* Harris test. Adaptation of the Harris Test of Lateral Dominance
* Single leg support time on a stable surface
* Satisfaction questionnaire for professionals
* Participant satisfaction questionnaire adapted to easy reading. The evaluations will be carried out by a professional external to the treatment to avoid bias.

Once the intervention period is over, a questionnaire will be passed to the professionals participating in the study to assess the usefulness of the device, the degree of satisfaction with it and the usefulness of the therapies applied, and a satisfaction questionnaire for participants adapted for easy reading. to know the degree of satisfaction and usefulness of the tool on the part of the participants.

TIMELINE

The intervention consists of 40 treatment sessions lasting 45 minutes each with a frequency of 2 days a week in which the intervention protocol described in Annex 7 described above will be developed. (15 min from Intorus) Previously, the participants will receive a "session 0" in which they will carry out a first contact with the device.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Down Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Down syndrome psychomotoricity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group

Group that will receive the intervention sessions using the Intorus tool

Group Type EXPERIMENTAL

INTORUS

Intervention Type DEVICE

INTERVENTION PROTOCOL WITH INTORUS

control group

Group that will receive the intervention sessions without using the Intorus tool

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

INTORUS

INTERVENTION PROTOCOL WITH INTORUS

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Users with Down Syndrome
* Ages between 4 and 18 years.
* Informed consent signed by parents/guardians.

Exclusion Criteria

* Users without Down Syndrome.
* Under 4 years and over 18 years
Minimum Eligible Age

4 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Extremadura

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Blanca González Sanchez

DOCTOR

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

BLANCA GONZÁLEZ SÁNCHEZ, DOCTOR

Role: PRINCIPAL_INVESTIGATOR

UNIERSIDAD DE EXTREMADURA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Blanca Gonzalez Sanchez

Cáceres, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ISD2023

Identifier Type: -

Identifier Source: org_study_id